Activation of ERK by altered RNA splicing in cancer
Y. Zhang, M. A. Siraj, P. Chakraborty, R. Tseng, L.-T. Ku, S. Das, A. Dey, S. K. D. Dwivedi, G. Rao, M. Zhang, D. Yang, M. N. Hossen, W.-Q. Ding, K.-M. Fung, R. Bhattacharya, , P. Mukherjee
The paper shows that SMNDC1, an upregulated splicing factor in cancer, promotes tumor growth by enhancing ERK1 kinase activity through altered RNA splicing of exon 4.
bioRxiv · Aug 31, 2022 · PreprintCancer Biology